Many QIAGEN Ingenuity Pathway Analysis (IPA) users have expressed interest in taking advantage of public single-cell expression data. Such data is readily available and easily accessible in IPA. We are […]
New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) […]
New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) […]
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries […]
Are you interested in exploring how you can evaluate phenotypic differences between custom cohorts? You can learn more about drug response, survival, co-expressing biomarkers, mutations and more based on gene expression. In this webinar, you'll learn how to investigate patient cohorts using high-quality curated genomic repositories like the QIAGEN OmicSoft Lands database. You'll be able […]
QIAGEN will be at the 36th European Congress of Pathology (ECP) in Florence from September 7-11, 2024, in Florence, Italy. At the event, be sure to check out our poster that we are presenting in collaboration with a leading pharmaceutical company showing how our clinical decision support software, QCI Interpret, provides rapid and accurate interpretation […]
Using CLC Genomics Workbench, we will go through a pipeline for analyzing metatranscriptome NGS data from microbial communities and perform pathways interpretation on it. Import "raw" NGS sequencing data and prepare the samples for analysis Find relevant annotated genomes with a curated reference database while removing ribosomal RNA with the SILVA database (database of rRNAs) […]
Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells. These unique molecular markers are highly visible to the immune system, making them ideal for personalized immunotherapies. They may also be able to predict both tumor survival prognosis and immune checkpoint blockade responses. Neoantigens are […]
Per feedback of scientists interested in taking advantage of non-oncological diseases (inflammatory, infectious, metabolic and more) as well as normal tissues (example toxicology/target safety assessment) omics, we are hosting this training focused OmicSoft Diseaseland. OmicSoft Diseaseland is a repository which contain high quality curated ‘omic data (RNA-seq, scRNA-seq, microarray and more) from diverse data-sources (example […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and compare different types of 'omics data. In this webinar, we’ll compare bulk RNA-seq and single-cell RNA-seq data to identify common regulators/targets and see how those regulators/targets associate with your phenotype of interest. We will also use sample-level public data to validate gene expression […]
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. You’ll learn to: Upload multiple dataset types (e.g., RNA-seq, proteomics, metabolomics) and perform interactive core/pathway analysis in IPA Learn how to interpret […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships […]
Watch Now
